Parving HH - Search Results

1

Improved prognosis of diabetic nephropathy in type 1 diabetes.

Andrésdóttir G, Jensen ML, Carstensen B, Parving HH, Hovind P, Hansen TW, Rossing P. Andrésdóttir G, et al. Among authors: parving hh. Kidney Int. 2015 Feb;87(2):417-26. doi: 10.1038/ki.2014.206. Epub 2014 Jun 11. Kidney Int. 2015. PMID: 24918158 Free article.

2

Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy.

Sørensen VB, Rossing P, Tarnow L, Parving H, Nørgaard T, Kastrup J. Sørensen VB, et al. Clin Sci (Lond). 1998 Dec;95(6):709-17. doi: 10.1042/cs0950709. Clin Sci (Lond). 1998. PMID: 9831696 Clinical Trial.

3

Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.

Rossing K, Christensen PK, Jensen BR, Parving HH. Rossing K, et al. Among authors: parving hh. Diabetes Care. 2002 Jan;25(1):95-100. doi: 10.2337/diacare.25.1.95. Diabetes Care. 2002. PMID: 11772908 Clinical Trial.

4

Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy.

Hansen HP, Hovind P, Jensen BR, Parving HH. Hansen HP, et al. Among authors: parving hh. Kidney Int. 2002 Jan;61(1):163-8. doi: 10.1046/j.1523-1755.2002.00092.x. Kidney Int. 2002. PMID: 11786097 Free article.

5

Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.

Rossing P, Hougaard P, Parving HH. Rossing P, et al. Among authors: parving hh. Diabetes Care. 2002 May;25(5):859-64. doi: 10.2337/diacare.25.5.859. Diabetes Care. 2002. PMID: 11978681

6

Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy.

Jacobsen P, Andersen S, Rossing K, Hansen BV, Parving HH. Jacobsen P, et al. Among authors: parving hh. Nephrol Dial Transplant. 2002 Jun;17(6):1019-24. doi: 10.1093/ndt/17.6.1019. Nephrol Dial Transplant. 2002. PMID: 12032191 Clinical Trial.

7

Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH. Andersen S, et al. Among authors: parving hh. Kidney Int. 2002 Jul;62(1):192-8. doi: 10.1046/j.1523-1755.2002.00410.x. Kidney Int. 2002. PMID: 12081578 Free article. Clinical Trial.

8

Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy.

Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH. Hansen HP, et al. Among authors: parving hh. Kidney Int. 2002 Jul;62(1):220-8. doi: 10.1046/j.1523-1755.2002.00421.x. Kidney Int. 2002. PMID: 12081581 Free article. Clinical Trial.

9

PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.

Jacobsen P, Grarup N, Tarnow L, Parving HH, Pedersen O. Jacobsen P, et al. Among authors: parving hh. Nephrol Dial Transplant. 2002 Aug;17(8):1408-12. doi: 10.1093/ndt/17.8.1408. Nephrol Dial Transplant. 2002. PMID: 12147787

10

Optimal dose of losartan for renoprotection in diabetic nephropathy.

Andersen S, Rossing P, Juhl TR, Deinum J, Parving HH. Andersen S, et al. Among authors: parving hh. Nephrol Dial Transplant. 2002 Aug;17(8):1413-8. doi: 10.1093/ndt/17.8.1413. Nephrol Dial Transplant. 2002. PMID: 12147788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

670 results

Search Page

Filters